Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor

Clinical trial NCT07331064 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07331064
Sponsor: Sarah Rumler
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

High Grade Gliomas Atypical Teratoid Rhabdoid Tumors (ATRT)Diffuse Midline Glioma DIPG Diffuse Intrinsic Pontine Gliomas (DIPG)

Start date: 2026-05-15
Primary completion: 2030-11-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.